Nurix Therapeutics Inc.

NASDAQ: NRIX · Real-Time Price · USD
11.20
-0.33 (-2.86%)
At close: May 01, 2025, 3:59 PM
11.16
-0.36%
After-hours: May 01, 2025, 05:48 PM EDT

Nurix Therapeutics Revenue

Nurix Therapeutics reported an annual revenue of $54.55M, reflecting a -29.15% growth. For the quarter ending February 28, 2025, Nurix Therapeutics generated $18.45M in revenue.
Revenue (ttm)
$54.55M
Revenue Growth
-29.15%
Price / Sales Ratio
27.21
Revenue / Employee
$190.73K
Employees
286
Market Cap
853.84M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Nov 30, 2024 54.55M -29.15%
Nov 30, 2023 76.99M +99.31%
Nov 30, 2022 38.63M +29.84%
Nov 30, 2021 29.75M +66.95%
Nov 30, 2020 17.82M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.